In a mouse model of metastatic breast cancer, natural killer (NK) T cell activation was shown to enhance antitumor immunity by increasing cytotoxic responses and interferon-γ production from NK and CD8+ T cells [7]. This evidence concerns the gene CD8A and breast cancer.